Current Problems in Cancer

Papers
(The TQCC of Current Problems in Cancer is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Table of Contents88
Information for Readers40
Information for Readers34
Artificial intelligence-based pathological application to predict regional lymph node metastasis in Papillary Thyroid Cancer32
Prognostic risk stratification using C-reactive protein, albumin, and associated inflammatory biomarkers in patients with advanced cancer in palliative care29
Comprehensive Pan-Cancer Analysis of MTF2 Effects on Human Tumors23
Table of Contents20
Electronic symptom monitoring improves chemotherapy dose intensity in neoadjuvant chemotherapy for breast cancer18
Mapping the intricacies of GLI1 in hedgehog signaling: A combined bioinformatics and clinical analysis in Head & Neck cancer in Western India17
Changing trends in disease burden of lung cancer in China from 1990-2019 and following 15-year prediction16
Dosing immune-checkpoint inhibitors: Opportunities for the future16
Efficacy of atezolizumab, bevacizumab, carboplatin, and paclitaxel for epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after tyrosine kinase inhibitor failure16
Information for Readers14
Angiogenesis biomarkers in prostate cancer: Unlocking new avenues for prognosis and diagnosis14
Title Page14
Title Page14
Information for Readers14
Do the recorded cases of oral cancer correspond to the actual numbers in India: The necessity of properly designed screening and surveying initiatives14
Long-term outcomes in patients with central and ultracentral non-small cell lung cancer treated with stereotactic body radiotherapy: single-institution experience13
Four versus six cycles of platinum-based chemotherapy for advanced Urothelial carcinoma in the era of immune checkpoint inhibitors: A retrospective cohort study (FOCUS, KCSG-GU23-08)13
The current state of proton radiotherapy13
Title Page13
Successful autologous stem cell transplantation in a case of multiple myeloma with mechanical heart valves13
Technological innovations enhancing palliative care in cancer: A new era of patient care in India13
Management of fertility preservation in young female patients with gastrointestinal cancer: A case series and systematic literature review12
Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer12
Primary and secondary prevention of cervical cancer among Italian AFAB transgender people12
The predictive value of hematological inflammatory markers for severe oral mucositis in patients with nasopharyngeal carcinoma during intensity-modulated radiation therapy: A retrospective cohort stud12
Title Page11
Risk factors for omental metastasis and the effect of omentectomy on survival in type 2 endometrial cancer patients10
Imaging of colon and rectal cancer10
MRI-fusion biopsy era: the role of perineural invasion in low-risk prostate cancer10
Hormone replacement therapy in endometrial cancer survivors: A retrospective cohort study on recurrence, survival, and quality of life9
Solitary bone plasmacytoma: Long-term clinical outcomes in a single center9
Combination of immunotherapy, radiotherapy and denosumab as the best approach even for NSCLC poor prognosis patients: a case report with strong response, prolonged survival and a review of literature9
Title Page9
Imaging of breast cancer–beyond the basics8
Information for Readers8
Safety of immune checkpoint inhibitors in patients with preexisting autoimmune disorders8
Barriers, blocks, and barricades: Disparities to access of palliative care in cancer care8
Prognostic significance of SIRI in patients with late-stage lung adenocarcinoma receiving EGFR-TKI treatment8
Title Page8
Title Page8
Borderline tumours of ovary and fertility preservation–Outcomes from a tertiary care center in India8
Dietary influence on cancer progression: Gut health and genomic profiles8
A novel model to predict the risk of hematological toxicity in lung adenocarcinoma patients with pemetrexed plus platinum chemotherapy based on real-world data7
Patient reported outcomes for symptom toxicity in breast cancer patients undergoing radiotherapy7
Clinical impact of a single time-point protocol paired FDG-PET and radioactive iodine scan for comprehensive disease assessment in differentiated thyroid cancer7
A Neoplastic Lesion in the Pineal Region7
MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence7
Efficacy and safety of toripalimab in treating nasopharyngeal carcinoma: A meta-analysis7
Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting6
Table of Contents6
Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors6
Is Hypoglycemia Secondary to Metastatic Retroperitoneal Sarcoma - A Therapeutic Challenge? Case Report and Review of Literature6
Current perspectives on Lifileucel tumor-infiltrating lymphocyte therapy: A paradigm shift in immunotherapy5
Clinical characteristics and treatment analysis of pulmonary blastoma (PB): a report of 17 cases5
Efficacy and safety of gene therapy approaches for malignant gliomas: A systematic review and meta-analysis5
Title Page5
Examining the Cultural Appropriateness of Advance Care Planning Tools for Adolescents and Young Adults With Cancer: An Example of Cross-Cultural Adaptation of the Voicing My CHOiCES Tool5
Current landscape of targeted therapy in esophageal squamous cell carcinoma5
Information for Readers5
Metaplastic breast cancer: Experience with ifosfamide based chemotherapy5
Information for Readers5
Information for Readers5
Creating a culture for change: Lessons from behavioral economics and complexity science to increase serious illness conversations for patients with cancer5
Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative)5
Table of Contents5
Capivasertib in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative advanced breast cancer5
Title Page5
Table of Contents5
Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies5
0.06519603729248